Translating Regenerative Medicine

BECOME A NEW MEMBER

Membership of Regener8 is free and it’s easy to sign up. Click here to become a member.

NEWSLETTER

LATEST EVENT

1 Jan 1970

Regener8 enables the translation of university and industry research in regenerative medicine into commercial products and clinical benefits.

By bringing together world-leading scientists in the N8 universities and beyond, translational clinicians and international industry, we enhance early stage innovation and develop translational capability to nurture technologies and understanding and progress regenerative therapies through to the clinic and the market.

TWITTER

FOLLOW US
A special Regener8 funding digest has been sent. Not recieved it? Read about the new Industry Proof-of-conept call https://t.co/WQzqGaemIH

23 Sep 2016
Med Tech Industry urged to bid in partnership for £100,000 proof-of-concept funding. https://t.co/WQzqGaemIH #medtech

21 Sep 2016
RT @medtechleeds: Regenerative cell therapy to promote colorectal wound healing https://t.co/CjDYGhEJPh

20 Jul 2016